The new risk-sharing paradigm in rare cancers: Patient perspective
Sign Up to like & getrecommendations! Published in 2017 at "Journal of cancer policy"
DOI: 10.1016/j.jcpo.2017.03.007
Abstract: Abstract Advances in understanding the biology of rare cancers and in genomic technologies are reshaping drug development and are fostering patients' hopes because an increasing number of drugs are expected to be made available. However,… read more here.
Keywords: risk sharing; new risk; rare cancers; sharing paradigm ... See more keywords